ISSCR News

Deepak Srivastava Becomes President of the ISSCR

  • 30 June, 2019
Srivastava-Deepak(Gladstone credit)

The ISSCR is pleased to announce Deepak Srivastava, MD, Gladstone Institutes, as the incoming president of the ISSCR and its board of directors. Srivastava assumed the post immediately following the 17th ISSCR Annual Meeting in Los Angeles, 26-29 June, 2019.

Srivastava, President of the Gladstone Institutes, Director of the Roddenberry Stem Cell Center, and professor of Pediatrics and Biochemistry and Biophysics at the University of California, San Francisco, will serve as ISSCR president for one year, succeeding Douglas Melton.

“This is a truly exciting time for stem cell science, as researchers have access to tools and technologies that are rapidly moving the field forward and leading to new approaches and potential applications for medicine,” said Srivastava. “In recent years, stem cell research has yielded insights into human biology, development, and disease that are now beginning to be translated into clinical application, with a number of therapies now or soon to be in clinical trial. For the first time, we have the opportunity to actually cure disease rather than accepting it.”

Srivastava’s research focuses on the molecular pathways that drive the development of the heart, leading to new regenerative therapies for congenital and adult heart disease. His laboratory uses multiple approaches including human genetics, molecular profiling, and induced pluripotent stem cells to uncover the mechanisms of disease in patients.

Christine Mummery, Professor of Developmental Biology at Leiden University Medical Centre and Chair of the Department of Anatomy and Embryology, is president-elect, and will become president in 2020. Melissa Little, Program Leader of Stem Cells Australia, researcher at the Murdoch Childrens Research Institute, and Professor at the University of Melbourne, is vice president, and will serve as president in 2021.

New members of the ISSCR leadership include Treasurer Kenneth Zaret, University of Pennsylvania, U.S., and re-appointed board members:

  • Marianne Bronner, California Institute of Technology, U.S.;
  • Valentina Greco, Yale University, U.S.;
  • Arnold Kriegstein, University of California San Francisco, U.S.

###